NEW YORK STATE COMMON RETIREMENT FUND - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 222 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$322
-70.8%
34,382
-23.6%
0.00%
-100.0%
Q2 2023$1,104
+24.5%
45,000
+18.0%
0.00%0.0%
Q1 2023$887
-54.3%
38,135
-50.3%
0.00%
-66.7%
Q4 2022$1,942
-99.9%
76,720
+2.4%
0.00%
+50.0%
Q3 2022$1,445,000
-28.7%
74,941
-5.8%
0.00%
-33.3%
Q2 2022$2,027,000
+82.0%
79,595
+83.8%
0.00%
+200.0%
Q1 2022$1,114,000
-38.6%
43,317
+0.1%
0.00%
-50.0%
Q4 2021$1,813,000
-4.1%
43,290
-0.3%
0.00%0.0%
Q3 2021$1,890,000
-23.1%
43,422
-16.4%
0.00%
-33.3%
Q2 2021$2,457,000
-1.2%
51,958
+7.1%
0.00%0.0%
Q1 2021$2,487,000
+91.5%
48,5000.0%0.00%
+200.0%
Q4 2020$1,299,000
-22.0%
48,5000.0%0.00%
-50.0%
Q3 2020$1,665,000
-4.4%
48,500
+14.1%
0.00%0.0%
Q2 2020$1,741,000
+519.6%
42,500
+418.3%
0.00%
Q1 2020$281,000
+172.8%
8,2000.0%0.00%
Q4 2019$103,0008,2000.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$30,100,00023.79%
SB INVESTMENT ADVISERS (UK) LTD 22,086,280$425,823,0003.26%
Zebra Capital Management LLC 40,104$773,0002.94%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 130,409$2,514,0000.94%
CLARK ESTATES INC/NY 180,000$3,470,0000.77%
Temasek Holdings (Private) Ltd 6,036,821$116,389,9090.70%
SECTOR GAMMA AS 89,808$1,731,0000.45%
Capital Impact Advisors, LLC 13,196$360,0000.36%
SummerHaven Investment Management, LLC 24,927$481,0000.33%
DUALITY ADVISERS, LP 92,712$1,787,0000.20%
View complete list of VIR BIOTECHNOLOGY INC shareholders